Background. Male breast cancer (MBC) is an uncommon disease and there is limited
information on the prognostic impact of routinely used clinicopathological parameters …

Aim: The aim of this study was to assess the molecular subtype profiles of male breast
cancer (MBC) and subsequent clinical outcome using a validated 6-marker …

Background Male breast cancer (MBC) is rare. Molecular subtype has been utilized widely
in female breast cancer. But the relationship between subtype and prognosis in MBC …

Abstract Purpose Male Breast Cancer (MBC) remains a poor understood disease.
Prognostic factors are not well established and specific prognostic subgroups are warranted …

Male breast cancer (MBC) is rare. We assembled 446 MBCs on tissue microarrays and
assessed clinicopathological information, together with data from 15 published studies …

Introduction Male breast cancer accounts for around 1% of all breast cancer cases but the
incidence has risen in recent years. This study aimed to classify the molecular subtypes of …

Background. Due to its rarity, male breast cancer (mBC) remains an inadequately
characterized disease, and current evidence for treatment derives from female breast cancer …

Male breast cancer is a rare disease that is still poorly understood. It is mainly classified by
immunohistochemistry as a luminal disease. In this study, we assess for the first time the …

Molecular subtyping of breast cancer by gene expression has proven its significance in
females. Immunohistochemical surrogates have been used for this classification, because …

Background Male breast cancer (BC) is rare, managed by extrapolation from female BC. The
International Male BC Program aims to better characterize and manage this disease. We …